Department of Pharmaceutical Sciences , North Dakota State University , Fargo , North Dakota 58105 , United States.
Department of Mechanical and Aerospace Engineering , George Washington University , Washington , D.C. 20052 , United States.
Mol Pharm. 2019 May 6;16(5):1789-1798. doi: 10.1021/acs.molpharmaceut.9b00104. Epub 2019 Apr 16.
Exosomes, biological extracellular vesicles, have recently begun to find use in targeted drug delivery in solid tumor research. Ranging from 30-120 nm in size, exosomes are secreted from cells and isolated from bodily fluids. Exosomes provide a unique material platform due to their characteristics, including physical properties such as stability, biocompatibility, permeability, low toxicity, and low immunogenicity-all critical to the success of any nanoparticle drug delivery system. In addition to traditional chemotherapeutics, natural products and RNA have been encapsulated for the treatment of breast, pancreatic, lung, prostate cancers, and glioblastoma. This review discusses current research on exosomes for drug delivery to solid tumors.
外泌体是一种生物细胞外囊泡,最近开始在实体瘤研究的靶向药物输送中得到应用。外泌体的大小在 30-120nm 之间,由细胞分泌并从体液中分离出来。由于其特性,包括稳定性、生物相容性、通透性、低毒性和低免疫原性等物理性质,外泌体提供了一个独特的物质平台,这些特性对于任何纳米药物输送系统的成功都至关重要。除了传统的化疗药物外,天然产物和 RNA 也被包裹用于治疗乳腺癌、胰腺癌、肺癌、前列腺癌和胶质母细胞瘤。本文综述了外泌体在实体瘤药物输送中的研究进展。